Aktie A0M3X2 NANJING PHARMACEUTICAL COMPANY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen NanJing Pharmaceutical Company Limited

Aktien

A0M3X2

CNE000000KV1

600713

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 07.06.2024 		% 5 Tage % 1. Jan.
4,55 CNY +1,34 % Intraday Chart für NanJing Pharmaceutical Company Limited -3,40 % -5,99 %
28.05. Nanjing Pharmaceutical emittiert ultrakurzfristige Anleihen im Wert von 500 Millionen Yuan MT
29.04. NanJing Pharmaceutical Company Limited meldet die Ergebnisse für das erste Quartal zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Nanjing Pharmaceutical Issues 500 Million Yuan Ultra-Short-Term Bonds
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
NanJing Pharmaceutical Company Limited(XSSC:600713) added to S&P Global BMI Index
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
NanJing Pharmaceutical Company Limited entered into Framework Agreement to acquire 55% stake in Suzhou Tianqing Xingwei Pharmaceutical Co., Ltd., a 55% stake in Zhejiang Tianqing Zhongwei Pharmaceutical Co., Ltd., and a 100% of Lianyungang Chia Tai-Tianqing Pharmaceutical Co., Ltd.
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
NanJing Medical’s Controlling Shareholder Boosts Stake to 44.2% For $158 Million
NanJing Pharmaceutical Company Limited announced that it has received CNY 997.999997 million in funding from Nanjing XinGong Investment Group Co., Ltd
Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited for CNY 19.9 million.
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021
NanJing Pharmaceutical Company Limited announced that it expects to receive CNY 999.999998 million in funding from Nanjing XinGong Investment Group Co., Ltd
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M3X2 Aktie
  4. Nachrichten NanJing Pharmaceutical Company Limited
  5. Andere Sprachen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT